Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches DOI Creative Commons
Zhoumeng Lin, Wei-Chun Chou, Yi‐Hsien Cheng

и другие.

International Journal of Nanomedicine, Год журнала: 2022, Номер Volume 17, С. 1365 - 1379

Опубликована: Март 1, 2022

Background: Low delivery efficiency of nanoparticles (NPs) to the tumor is a critical barrier in field cancer nanomedicine. Strategies on how improve NP remain be determined. Methods: This study analyzed roles physicochemical properties, models, and types using multiple machine learning artificial intelligence methods, data from recently published Nano-Tumor Database that contains 376 datasets generated physiologically based pharmacokinetic (PBPK) model. Results: The deep neural network model adequately predicted different NPs tumors it outperformed all other methods; including random forest, support vector machine, linear regression, bagged methods. adjusted determination coefficients (R 2 ) full training dataset were 0.92, 0.77, 0.77 0.76 for maximum (DE max ), at 24 h 168 last sampling time Tlast ). corresponding R values test 0.70, 0.46, 0.33 0.63, respectively. Also, this showed type was an important determinant predicting across endpoints (19– 29%). Among Zeta potential core material played greater role than such as type, shape, targeting strategy. Conclusion: provides quantitative design nanomedicine with efficiency. These results help our understanding causes low demonstrates feasibility integrating PBPK modeling approaches Graphical Abstract: Keywords: intelligence, learning, modeling, nanomedicine, drug delivery, nanotechnology

Язык: Английский

Engineering precision nanoparticles for drug delivery DOI Open Access
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley

и другие.

Nature Reviews Drug Discovery, Год журнала: 2020, Номер 20(2), С. 101 - 124

Опубликована: Дек. 4, 2020

Язык: Английский

Процитировано

5323

Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval DOI
Duhyeong Hwang, Jacob D. Ramsey, Alexander V. Kabanov

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2020, Номер 156, С. 80 - 118

Опубликована: Янв. 1, 2020

Язык: Английский

Процитировано

469

The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors DOI Creative Commons

Mukaddes Izci,

Christy Maksoudian, Bella B. Manshian

и другие.

Chemical Reviews, Год журнала: 2021, Номер 121(3), С. 1746 - 1803

Опубликована: Янв. 14, 2021

Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a decade. Classically, scientists have tried improve NM by employing passive or active targeting strategies, making use so-called enhanced permeability and retention (EPR) effect. This phenomenon is made possible due leaky tumor vasculature through which NMs can leave bloodstream, traverse gaps in endothelial lining vessels, enter tumor. Recent studies shown that despite many efforts employ EPR effect, this process remains very poor. Furthermore, role effect called into question, where it suggested

Язык: Английский

Процитировано

352

Obstacles and opportunities in a forward vision for cancer nanomedicine DOI
Irene de Lázaro, David Mooney

Nature Materials, Год журнала: 2021, Номер 20(11), С. 1469 - 1479

Опубликована: Июль 5, 2021

Язык: Английский

Процитировано

330

Polymeric Nanoparticles for Drug Delivery DOI
Maximilian A. Beach,

Umeka Nayanathara,

Yanting Gao

и другие.

Chemical Reviews, Год журнала: 2024, Номер 124(9), С. 5505 - 5616

Опубликована: Апрель 16, 2024

The recent emergence of nanomedicine has revolutionized the therapeutic landscape and necessitated creation more sophisticated drug delivery systems. Polymeric nanoparticles sit at forefront numerous promising designs, due to their unmatched control over physiochemical properties such as size, shape, architecture, charge, surface functionality. Furthermore, polymeric have ability navigate various biological barriers precisely target specific sites within body, encapsulate a diverse range cargo efficiently release this in response internal external stimuli. However, despite these remarkable advantages, presence wider clinical application is minimal. This review will provide comprehensive understanding vehicles. affecting be outlined first, followed by description nanoparticle designs preparation methods, beginning with polymers on which they are based. meticulously explore current performance against myriad diseases including cancer, viral bacterial infections, before finally evaluating advantages crucial challenges that determine potential decades come.

Язык: Английский

Процитировано

236

Artificial exosomes for translational nanomedicine DOI Creative Commons
Yongjiang Li, Junyong Wu, Jihua Liu

и другие.

Journal of Nanobiotechnology, Год журнала: 2021, Номер 19(1)

Опубликована: Авг. 12, 2021

Abstract Exosomes are lipid bilayer membrane vesicles and emerging as competent nanocarriers for drug delivery. The clinical translation of exosomes faces many challenges such massive production, standard isolation, loading, stability quality control. In recent years, artificial based on nanobiotechnology to overcome the limitations natural exosomes. Major types include ‘nanovesicles (NVs)’, ‘exosome-mimetic (EM)’ ‘hybrid (HEs)’, which obtained by top-down, bottom-up biohybrid strategies, respectively. Artificial powerful alternatives Here, we outline advances in through discuss their strengths, future perspectives. development holds great values translational nanomedicine.

Язык: Английский

Процитировано

232

Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics DOI
Nem Singh, Subin Son, Jusung An

и другие.

Chemical Society Reviews, Год журнала: 2021, Номер 50(23), С. 12883 - 12896

Опубликована: Янв. 1, 2021

Finding a personalized nano theranostics solution, nanomedicine for cancer diagnosis and therapy, is among the top challenges of current medicinal science. Porous organic polymers (POPs) are permanent porous materials prepared by linking relatively rigid multidimensional building blocks. POP nanoparticles have remarkable advantage owing to their specific physicochemical characteristics such as high surface area, convincing pore size engineering, stimuli-responsive degradability, negligible toxicity, open covalent post-synthesis modification possibilities etc. POPs crystalline non-crystalline characteristics; popularly known frameworks (COFs), shown potential application across research areas in The early development on applications nanoscale has tremendous future clinical translation. This tutorial review highlights recently developed promising nPOPs drug loading, targeted delivery, endogenous exogenous release, imaging combination regardless poorly properties. will provide platform translation solving fundamental nanomedicines loading efficiency, size-optimization, biocompatibility, dispersibility cell uptake ability.

Язык: Английский

Процитировано

157

Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle DOI Creative Commons
Qianqian Li, Zhaoqing Shi, Fan Zhang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2021, Номер 12(1), С. 107 - 134

Опубликована: Июнь 2, 2021

The immune system is involved in the initiation and progression of cancer. Research on cancer immunity has contributed to development several clinically successful immunotherapies. These immunotherapies often act a single step cancer-immunity cycle. In recent years, discovery new nanomaterials dramatically expanded functions potential applications nanomaterials. addition acting as drug-delivery platforms, some can induce immunogenic cell death (ICD) cells or regulate profile strength response immunomodulators. Based their versatility, may serve an integrated platform for multiple drugs therapeutic strategies, simultaneously targeting steps cycle enhance outcome anticancer response. To illustrate critical roles based cycle, this review will comprehensively describe crosstalk between cancer, current nanomaterials, including drug carriers, ICD inducers, Moreover, provide detailed discussion knowledge regarding developing combinational hoping maximize efficacy these treatments assisted by

Язык: Английский

Процитировано

112

Stealth and pseudo-stealth nanocarriers DOI Creative Commons

Panyue Wen,

Wendong Ke,

Anjaneyulu Dirisala

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2023, Номер 198, С. 114895 - 114895

Опубликована: Май 19, 2023

Язык: Английский

Процитировано

112

Applications and challenges of ultra-small particle size nanoparticles in tumor therapy DOI
Jiaqi Xu,

Mengdi Song,

Zhou Fang

и другие.

Journal of Controlled Release, Год журнала: 2022, Номер 353, С. 699 - 712

Опубликована: Дек. 15, 2022

Язык: Английский

Процитировано

106